0.3668
Precedente Chiudi:
$0.3691
Aprire:
$0.38
Volume 24 ore:
71,914
Relative Volume:
0.20
Capitalizzazione di mercato:
$10.40M
Reddito:
-
Utile/perdita netta:
$-435.00K
Rapporto P/E:
-23.36
EPS:
-0.0157
Flusso di cassa netto:
$-665.30K
1 W Prestazione:
+9.49%
1M Prestazione:
-15.68%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Nome
Curanex Pharmaceuticals Inc
Settore
Industria
Telefono
718-673-6078
Indirizzo
2 JERICHO PLAZA,, JERICHO
Confronta CURX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CURX
Curanex Pharmaceuticals Inc
|
0.3668 | 10.46M | 0 | -435.00K | -665.30K | -0.0157 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Curanex Pharmaceuticals Inc Borsa (CURX) Ultime notizie
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Canada
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Inc Announces Chief Financial Officer Changes - marketscreener.com
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to S&P TMI Index - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Weekly Research Analysts’ Ratings Updates for Curanex Pharmaceuticals (CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) is looking forward to a strong quarter - setenews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Curanex Pharmaceuticals Faces Nasdaq Delisting Warning - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Wall Street Zen Downgrades Curanex Pharmaceuticals (NASDAQ:CURX) to Sell - Defense World
Curanex Pharmaceuticals Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
Curanex Pharmaceuticals Inc SEC 10-Q Report - TradingView
Curanex Pharmaceuticals receives Nasdaq notice on minimum bid price requirement - Investing.com India
Curanex Pharmaceuticals IncCommon Stock (NQ: CURX - FinancialContent
Curanex engages Strategic Investor Relations to enhance Curanex’s visibility - MSN
Curanex Pharmaceuticals (CURX): An Emerging Force in US Botanical Drug Development - Markets Financial Content
Curanex Pharmaceuticals (CURX): An Emerging Force In US Botanical Drug Development - Menafn.com
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement - The Manila Times
Curanex Pharmaceuticals Inc. Engages Strategic Investor - GlobeNewswire
Price performance - Yahoo
Curanex Pharmaceuticals Inc Azioni (CURX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):